Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024
Corvus Pharmaceuticals (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, has announced a conference call and webcast scheduled for August 6, 2024, at 4:30 pm ET (1:30 pm PT). The event will provide a business update and report second quarter 2024 financial results. Interested parties can access the call by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international), or by using a provided link for instant telephone access. A live webcast will be available through the investor relations section of Corvus' website, with a replay accessible for 90 days post-event.
Corvus Pharmaceuticals (NASDAQ: CRVS), un'azienda biofarmaceutica in fase clinica, ha annunciato una conferenza telefonica e un webcast fissati per il 6 agosto 2024, alle 16:30 EST (13:30 PST). L'evento fornirà un aggiornamento aziendale e riporterà i risultati finanziari del secondo trimestre 2024. Le parti interessate possono accedere alla chiamata componendo il numero 1-800-717-1738 (numero verde nazionale) oppure 1-646-307-1865 (internazionale), oppure utilizzando un link fornito per l'accesso telefonico immediato. Un webcast in diretta sarà disponibile nella sezione delle relazioni con gli investitori del sito web di Corvus, con una registrazione accessibile per 90 giorni dopo l'evento.
Corvus Pharmaceuticals (NASDAQ: CRVS), una empresa biofarmacéutica en etapa clínica, ha anunciado una conferencia telefónica y un webcast programados para el 6 de agosto de 2024, a las 16:30 ET (13:30 PT). El evento proporcionará una actualización empresarial e informará sobre los resultados financieros del segundo trimestre de 2024. Las partes interesadas pueden acceder a la llamada marcando el 1-800-717-1738 (número gratuito nacional) o el 1-646-307-1865 (internacional), o utilizando un enlace proporcionado para acceso telefónico instantáneo. Un webcast en vivo estará disponible a través de la sección de relaciones con inversionistas del sitio web de Corvus, con una repetición accesible durante 90 días después del evento.
Corvus Pharmaceuticals (NASDAQ: CRVS)는 임상 단계의 생명공학 기업으로, 2024년 8월 6일 오후 4:30 ET (오후 1:30 PT)로 예정된 전화 회의 및 웹캐스트를 발표했습니다. 이 행사에서는 사업 업데이트 및 2024년 2분기 재무 결과 보고가 이루어질 것입니다. 관심 있는 분들은 1-800-717-1738 (국내 무료) 또는 1-646-307-1865 (국제)로 전화하여 회의에 접속하거나 제공된 링크를 사용하여 즉시 전화로 접속할 수 있습니다. 생방송 웹캐스트는 Corvus의 웹사이트 투자자 관계 섹션을 통해 제공되며, 이벤트 후 90일 동안 재생이 가능합니다.
Corvus Pharmaceuticals (NASDAQ: CRVS), une entreprise biopharmaceutique en phase clinique, a annoncé une conférence téléphonique et un webcast prévus pour le 6 août 2024 à 16h30 ET (13h30 PT). L'événement fournira une mise à jour sur les affaires et présentera les résultats financiers du deuxième trimestre 2024. Les parties intéressées peuvent accéder à l'appel en composant le 1-800-717-1738 (numéro gratuit national) ou le 1-646-307-1865 (international), ou en utilisant un lien fourni pour un accès téléphonique instantané. Un webcast en direct sera disponible dans la section des relations avec les investisseurs du site Web de Corvus, avec une rediffusion accessible pendant 90 jours après l'événement.
Corvus Pharmaceuticals (NASDAQ: CRVS), ein biopharmazeutisches Unternehmen in klinischer Phase, hat einen Telefonkonferenz und Webcast für den 6. August 2024 um 16:30 Uhr ET (13:30 Uhr PT) angekündigt. Die Veranstaltung wird ein Geschäftsupdate und die Berichterstattung über die finanziellen Ergebnisse des zweiten Quartals 2024 enthalten. Interessierte Parteien können die Konferenz unter 1-800-717-1738 (innerhalb der USA gebührenfrei) oder 1-646-307-1865 (international) kontaktieren oder einen bereitgestellten Link für den sofortigen Telefonzugang verwenden. Ein Live-Webcast wird über den Bereich Investor Relations auf der Website von Corvus verfügbar sein, mit einer Wiederholung, die 90 Tage nach der Veranstaltung zugänglich ist.
- None.
- None.
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT
BURLINGAME, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 6, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update and report second quarter 2024 financial results.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) or by clicking on this link for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website for 90 days.
About Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of cancer and immune diseases. The Company’s lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com.
INVESTOR CONTACT:
Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
llea@corvuspharma.com
MEDIA CONTACT:
Sheryl Seapy
Real Chemistry
+1-949-903-4750
sseapy@realchemistry.com
FAQ
When will Corvus Pharmaceuticals (CRVS) report its Q2 2024 financial results?
How can investors access Corvus Pharmaceuticals' (CRVS) Q2 2024 earnings call?
Will there be a replay available for Corvus Pharmaceuticals' (CRVS) Q2 2024 earnings webcast?
